PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq:AFFY), a clinical-stage pharmaceutical company, today announced the appointment of Hollings C. Renton to the company’s board of directors.
PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq:AFFY), a clinical-stage pharmaceutical company, today announced the appointment of Hollings C. Renton to the company’s board of directors.